32 related articles for article (PubMed ID: 21272884)
1. Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.
Desai KT; Hansen N; Rodriguez AC; Befano B; Egemen D; Gage JC; Wentzensen N; Lopez C; Jeronimo J; de Sanjose S; Schiffman M
Prev Med; 2024 Mar; 180():107881. PubMed ID: 38286273
[TBL] [Abstract][Full Text] [Related]
2. Addressing cervical cancer screening disparities through advances in artificial intelligence and nanotechnologies for cellular profiling.
Yang Z; Francisco J; Reese AS; Spriggs DR; Im H; Castro CM
Biophys Rev (Melville); 2021 Mar; 2(1):011303. PubMed ID: 33842926
[TBL] [Abstract][Full Text] [Related]
3. Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.
Katanga J; Kjaer SK; Manongi R; Wu CS; Iftner T; Waldstrom M; Pembe AB; Mwaiselage J; Rasch V
PLoS One; 2019; 14(6):e0218559. PubMed ID: 31216333
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.
Maza M; Alfaro K; Garai J; Velado MM; Gage JC; Castle PE; Felix J; Luciani S; Campos N; Kim J; Masch R; Cremer M
Gynecol Oncol Rep; 2017 May; 20():58-61. PubMed ID: 28337474
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician.
Raifu AO; El-Zein M; Sangwa-Lugoma G; Ramanakumar A; Walter SD; Franco EL;
PLoS One; 2017; 12(1):e0170631. PubMed ID: 28107486
[TBL] [Abstract][Full Text] [Related]
6. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
[TBL] [Abstract][Full Text] [Related]
7. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.
Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R
Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods.
Leslie HH; Karasek DA; Harris LF; Chang E; Abdulrahim N; Maloba M; Huchko MJ
PLoS One; 2014; 9(6):e101090. PubMed ID: 24979709
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Leslie HH; Abdulrahim N; Maloba M; Bukusi E; Cohen CR
Bull World Health Organ; 2014 Mar; 92(3):195-203. PubMed ID: 24700979
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Sneden J; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2014 Feb; 134(3):740-5. PubMed ID: 23900762
[TBL] [Abstract][Full Text] [Related]
11. Visual inspection with acetic acid for detection of high grade lesion in atypical squamous cells and low grade squamous intraepithelial lesions from cervical Pap smear.
Pothisuwan M; Pataradool K; Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Thawaramorn T
J Gynecol Oncol; 2011 Sep; 22(3):145-51. PubMed ID: 21998756
[TBL] [Abstract][Full Text] [Related]
12. See-and-treat approaches to cervical cancer prevention for HIV-infected women.
Chibwesha CJ; Cu-Uvin S
Curr HIV/AIDS Rep; 2011 Sep; 8(3):192-9. PubMed ID: 21706187
[TBL] [Abstract][Full Text] [Related]
13. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.
Basu PS; Sankaranarayanan R; Mandal R; Roy C; Das P; Choudhury D; Bhattacharya D; Chatterjee R; Dutta K; Barik S; Tsu V; Chakrabarti RN; Siddiqi M;
Int J Gynecol Cancer; 2003; 13(5):626-32. PubMed ID: 14675346
[TBL] [Abstract][Full Text] [Related]
14. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India.
Sankaranarayanan R; Wesley R; Thara S; Dhakad N; Chandralekha B; Sebastian P; Chithrathara K; Parkin DM; Nair MK
Int J Cancer; 2003 Sep; 106(3):404-8. PubMed ID: 12845681
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 2 cervical screening methods in Mongolia: cervical cytology and visual inspection with acetic acid.
Elit L; Baigal G; Tan J; Munkhtaivan A
J Low Genit Tract Dis; 2006 Apr; 10(2):83-8. PubMed ID: 16633236
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.
Mustafa RA; Santesso N; Khatib R; Mustafa AA; Wiercioch W; Kehar R; Gandhi S; Chen Y; Cheung A; Hopkins J; Ma B; Lloyd N; Wu D; Broutet N; Schünemann HJ
Int J Gynaecol Obstet; 2016 Mar; 132(3):259-65. PubMed ID: 26851054
[TBL] [Abstract][Full Text] [Related]
17. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
18. Adequacy of visual inspection with acetic acid in women of advancing age.
Cremer M; Conlisk E; Maza M; Bullard K; Peralta E; Siedhoff M; Alonzo T; Felix J
Int J Gynaecol Obstet; 2011 Apr; 113(1):68-71. PubMed ID: 21272884
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
